HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

STG-175

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Cyclosporins: 35
      - STG-175: 1
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Cyclosporins: 35
      - STG-175: 1

Experts

1.	Bobardt, Michael D: 1 article (01/2016)
2.	Chatterji, Udayan: 1 article (01/2016)
3.	Gallay, Philippe A: 1 article (01/2016)
4.	Long, Zhengyu: 1 article (01/2016)
5.	Su, Zhuang: 1 article (01/2016)
6.	Zhang, Shengli: 1 article (01/2016)

Related Diseases

1.	Coinfection 01/01/2016 - "Altogether these results suggest that the new CypI STG-175 represents an attractive drug partner for IFN-free DAA regimens for the treatment of HCV and co-infections."
2.	Infections 01/01/2016 - "STG-175 inhibits the infection of HCV, HIV-1 and HBV in mono-, dual- and triple-infection settings. "